Literature DB >> 8564346

Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer.

K V Rolston1, N Dholakia, S Rodriguez, E B Rubenstein.   

Abstract

Fifty febrile episodes in patients with hepatobiliary and pancreatic cancer were reviewed. Biliary obstruction often resulting in cholangitis was an important predisposing factor, whereas neutropenia (< 500 PMN/mm3) was uncommon (10%). Microbiologically documented infections originating from the gastrointestinal tract were predominant, with Enterococcus faecalis and Escherichia coli being isolated most often. Non-infectious causes of fever occurred in 16% of patients. Only one patient developed a fungal infection. The overall response rate to therapy was 94%, with 32% being eligible for outpatient management. These data are quite different from those generated from patients with hematologic malignancies and indicate that disease-site specific management guidelines need to be developed for febrile episodes in patients with various underlying neoplasms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564346     DOI: 10.1007/bf00364982

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  8 in total

Review 1.  From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

Authors:  W T Hughes; D Armstrong; G P Bodey; R Feld; G L Mandell; J D Meyers; P A Pizzo; S C Schimpff; J L Shenep; J C Wade
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

Review 3.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

Review 4.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

Review 5.  The changing epidemiology of infections at cancer hospitals.

Authors:  B S Koll; A E Brown
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

6.  Outpatient treatment of febrile neutropenic patients with cancer.

Authors:  E B Rubenstein; K V Rolston
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

7.  Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome.

Authors:  S al-Bahar; R Pandita; B N Dhabhar; E al-Bahar
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

8.  Cancer statistics, 1995.

Authors:  P A Wingo; T Tong; S Bolden
Journal:  CA Cancer J Clin       Date:  1995 Jan-Feb       Impact factor: 508.702

  8 in total
  4 in total

1.  Fungal infections in cancer patients: any progress?

Authors:  P Reusser
Journal:  Support Care Cancer       Date:  1995-11       Impact factor: 3.603

Review 2.  Infections in Cancer Patients with Solid Tumors: A Review.

Authors:  Kenneth V I Rolston
Journal:  Infect Dis Ther       Date:  2017-02-03

Review 3.  Microbes and Cancer: Friends or Faux?

Authors:  Maria Manuel Azevedo; Cidália Pina-Vaz; Fátima Baltazar
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 4.  Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Authors:  Ondřej Kubeček; Pavla Paterová; Martina Novosadová
Journal:  Life (Basel)       Date:  2021-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.